BioNexus Gene Lab Corporation (BGLC)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Revenue | 2.87M | 2.38M | 2.88M | 2.75M | 2.25M | 2.58M | 2.7M | 3.1M |
Operating Income | -123k | -168k | -155k | -2.53M | 257k | -79k | 259k | -1.34M |
Pre Tax Income | -127k | -53k | -275k | -2.53M | 253k | -84k | 255k | -1.34M |
Net Income | -157k | -69k | -259k | -2.61M | 307k | -104k | 199k | -1.35M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -123k | -51k | -155k | -2.53M | 257k | -79k | 259k | -1.34M |
EBITDA | -99k | -147k | -134k | -2.51M | 277k | -59k | 279k | -1.3M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 12.28M | 13.43M | 11.11M | 10.26M |
Operating Income | 1.27M | 1.06M | -291k | -2.59M |
Pre Tax Income | 1.26M | 1.04M | -303k | -2.61M |
Net Income | 1.09M | 752k | -356k | -2.63M |
Preferred Dividends | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.011 | 0.004 | -0.002 | -0.149 |
EBIT | 1.27M | 1.06M | -291k | -2.59M |
EBITDA | 1.36M | 1.15M | -200k | -2.51M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.